Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Cidara Therapeutics (CDTX) Non Operating Investment Income: 2018-2019

  • Cidara Therapeutics' Non Operating Investment Income was N/A to $681,000 in Q2 2019 from the same period last year, while for Jun 2019 it was $5.4 million, marking a year-over-year change of. This contributed to the annual value of $411,000 for FY2019, which is 89.46% down from last year.
  • According to the latest figures from Q2 2019, Cidara Therapeutics' Non Operating Investment Income is $681,000, which was up 327.00% from -$300,000 recorded in Q1 2019.
  • In the past 5 years, Cidara Therapeutics' Non Operating Investment Income ranged from a high of $4.1 million in Q4 2018 and a low of -$300,000 during Q1 2019.
  • Its 2-year average for Non Operating Investment Income is $1.3 million, with a median of $784,500 in 2018.